Skip to content
Ambroxol
Ambroxol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target lysosomal acid glucosylceramidase.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
R: Respiratory system drugs
R03: Drugs for obstructive airway diseases
R03C: Adrenergics for systemic use
R03CC: Selective beta-2-adrenoreceptor agonists, systemic
R03CC63: Clenbuterol and ambroxol
R05: Cough and cold preparations
R05C: Expectorants, excl. combinations with cough suppressants
R05CB: Mucolytics
R05CB06: Ambroxol
HCPCS
No data
Clinical
Clinical Trials
28 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Critical illnessD01663811
PneumoniaD011014EFO_0003106J1811
Healthcare-associated pneumoniaD00007729911
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharyngitisD010612R07.0145
Respiratory tract diseasesD01214011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parkinson diseaseD010300EFO_0002508G2033
Gaucher diseaseD005776Orphanet_355E75.22122
CoughD003371HP_0012735R0511
DementiaD003704F0311
Lewy body diseaseD020961EFO_0006792G31.83111
PainD010146EFO_0003843R5211
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients77
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetic neuropathiesD003929EFO_100078311
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAMBROXOL
INNambroxol
Description
Ambroxol is an aromatic amine.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1
Identifiers
PDB
CAS-ID18683-91-5
RxCUI625
ChEMBL IDCHEMBL153479
ChEBI ID
PubChem CID2132
DrugBankDB06742
UNII ID200168S0CL (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
GBA1
GBA1
Organism
Homo sapiens
Gene name
GBA1
Gene synonyms
GBA, GC, GLUC
NCBI Gene ID
Protein name
lysosomal acid glucosylceramidase
Protein synonyms
Acid beta-glucosidase, Alglucerase, Beta-GC, Beta-glucocerebrosidase, Beta-glucosylceramidase 1, Cholesterol glucosyltransferase, Cholesteryl-beta-glucosidase, D-glucosyl-N-acylsphingosine glucohydrolase, glucocerebrosidase, glucosidase, beta, acid, Glucosylceramidase beta 1, glucosylceramidase-like protein, Imiglucerase, lysosomal acid GCase, Lysosomal cholesterol glycosyltransferase, Lysosomal galactosylceramidase, lysosomal glucocerebrosidase, Lysosomal glycosylceramidase, SGTase
Uniprot ID
Mouse ortholog
Gba1 (14466)
lysosomal acid glucosylceramidase (Q78NR7)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,961 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
592 adverse events reported
View more details